Millipore Sigma Vibrant Logo
Attention: We have moved. EMD Millipore products are no longer available for purchase on emdmillipore.com.Learn More

AGX806 2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6)

This E. coli recombinant protein 2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6), Cat. No. AGX806 is tested for use in Lateral Flow Assay.

View Products on Sigmaaldrich.com
AGX806
1 mg  
Purchase on Sigma-Aldrich

Overview

Replacement Information
Description
Catalogue NumberAGX806
Description2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6)
Alternate Names
  • SARS-CoV
  • SARS-CoV-2
Background InformationCoronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 nucleocapsid antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).
References
Product Information
FormatPurified
PresentationPurified protein in 10 mM Phosphate buffer, 150 mM NaCl with no preservatives, pH 7.4.
Quality LevelMQ100
Applications
ApplicationThis E. coli recombinant protein 2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6), Cat. No. AGX806 is tested for use in Lateral Flow Assay.
Key Applications
  • Immunodiffusion
Application NotesOther recommended antigen products for lateral flow application are AGX804 or AGX808.
Biological Information
CloneN/A
ConcentrationPlease refer to guidance on suggested starting dilutions and/or titers per application and sample type.
SpecificitySARS-CoV-2
Purification MethodColumn Purification
UniProt Number
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles.
Packaging Information
Material Size1 mg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalog Number GTIN
AGX806 04061842457885

Documentation

2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6) SDS

Title

Safety Data Sheet (SDS) 

2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6) Certificates of Analysis

TitleLot Number
2019-nCoV Nucleocapsid Recombinant Antigen, full length (Ag-6) - 3590411 3590411
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6) - 3601705 3601705
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6) - 3608667 3608667
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6) - 3693111 3693111
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6) - 3694756 3694756
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6) - 3701839 3701839
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6) - 3780592 3780592
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6) - 3788633 3788633
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6) - 3788636 3788636
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6) - 3821522 3821522
Show more